Method for preparing biapenem by using micro-reaction technology
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 周小明
- Publication Date
- 2014-06-18
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of medicine preparation, and in particular provides a method for preparing biapenem by using micro-reaction technology. Background technique
[0002] Biapenem (Biapenem) is a 1β-methylcarbapenem antibiotic for injection developed by Lederle Company of Japan and Cyanoamide Company of the United States. It was approved for marketing in Japan in March 2002 and is currently undergoing Phase II clinical trials in the United States. test. Like meropenem, biapenem has the characteristics of broad antibacterial spectrum and strong antibacterial activity. Biapenem has strong antibacterial activity against Gram-positive bacteria, Gram-negative bacteria (including drug-resistant Pseudomonas aeruginosa), anaerobic bacteria, etc.; it is stable to β-lactamase; it is stable to DHP-1 Stronger than imipenem. Compared with other carbapenems on the market, biapenem has almost zero nephrotoxicity, can be administered alone, has no cen...